Message #16 From:
NewsBot Date: October 18, 2006 06:01:00 AM
DSCI News Derma Sciences Announces Renewal of Sales Agreement with Largest Customer in Canada
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (OTCBB: DSCI), a manufacturer and full line
supplier of wound and skin care products, today announced that the
Company has renewed its sales agreement with HealthPRO
Procurement Services. HealthPRO, headquartered in Toronto, is
Canada’s largest National Procurement Services
Organization, and is currently Derma Sciences’
largest Canadian customer. The renewal begins as of December 1, 2006 and
extends until November 30, 2011. The five-year agreement is an exclusive
arrangement between HealthPRO and Derma Sciences and covers Derma
Sciences’ general wound care products in
Canada. General wound care includes operating room products such as
sponges, dressings and bandages.
“We are very pleased to have signed this
renewal,” said Edward J. Quilty, Chairman,
President and CEO. “Signing our largest
Canadian customer to a long term deal is a significant step for us. Not
only does it represent a significant source of revenue on its own
merits, but by securing this revenue we free up our energies to
concentrate on expanding our business into other areas as well.”
Cynthia Shanahan, Vice President, Materials Management at HealthPROcommented
“Our experience with Derma Sciences has given
us confidence in the quality of their products and their commitment to
customer service. Those aspects – along with
the significant savings that these contracts deliver, make this very
good news for HealthPRO members.”
About Derma Sciences, Inc.
Derma Sciences, Inc. provides a full range of skin care; wound
management and specialty securement devices that are used primarily in
the professional markets, specifically hospitals, nursing homes and home
care settings. For more information about Derma Sciences, Inc., visit
its home page on the Internet at http://www.dermasciences.com.
HealthPRO is a Canadian corporation, formed in 1996, owned by and
responsible to its shareholders/customers. The HealthPROmandate
is to provide shareholders with high quality, cost effective procurement
support, and unique services, such as product standardization, supply
chain management tools, networks for best practices and clinical
education. Current product and service categories include Pharmacy
Services, Clinical Services and Clinical Specialties, Energy Management,
Nutrition & Food Services and Special Services.
Statements contained in this release that are not statements of
historical fact may be deemed to be forward-looking statements. Without
limiting the generality of the foregoing, words such as “may,”“will,”“expect,”“believe,”“anticipate,”“intend,”“could,”“estimate” or “continue”
are intended to identify forward-looking statements. Readers are
cautioned, that certain important factors may affect the Company’s
actual results and could cause such results to differ materially from
any forward-looking statements which may be made in this release or
which are otherwise made by or on behalf of the Company. Factors which
may affect the Company’s results include, but
are not limited to, product demand, market acceptance, impact of
competitive products and prices, product development, completion of an
acquisition, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and economic
risks. Additional factors that could cause or contribute to differences
between the Company’s actual results and
forward-looking statements Include but are not limited to, those
discussed in the Company’s filings with the
Securities and Exchange Commission.
